Company news

ProtoKinetix, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

ProtoKinetix Completes Non-Brokered Private Placement & Secures Operating Line of Credit

June 16, 2016

ProtoKinetix’ AAGP™ has been Published in the Journal of Tissue Engineering and Regenerative Medicine

June 7, 2016

ProtoKinetix Updates Progress Toward Clinical Trial Application for AAGP™

May 12, 2016

AAGP™ Improves Results in Stem Cells Transplanted in Retina Tissue by 300%

May 2, 2016

ProtoKinetix Outlines Steps to Clinical Trial Application for AAGP™

April 26, 2016

ProtoKinetix Corporate Update

January 5, 2016

AAGP™ Found to Significantly Improve Islet Cell Transplantation in Type 1 Diabetes Patients

December 17, 2015

ProtoKinetix Completes Private Placement

November 9, 2015

ProtoKinetix Begins Testing Diabetic Mice with AAGP™ at the University of Alberta

September 18, 2015

ProtoKinetix’ AAGP™ to Be Presented at the Congress of the International Pancreas and Islet Transplant Association

September 10, 2015

ProtoKinetix Reports on Its Strong Collaboration with the James Shapiro Laboratory at the University of Alberta

August 4, 2015

ProtoKinetix Announces Appointment of New Director and Provides Corporate Update

July 1, 2015

ProtoKinetix Upgrades to OTCQB

June 8, 2015

CEO Clarence Smith Reports on Edmonton Meetings with Dr. James Shapiro and his Team

June 5, 2015

OTC Markets Group Welcomes Newly Verified OTCQB Companies – June 5

June 5, 2015

British Columbia Securities Commission - Cease Trade Order

May 9, 2013

Revocation of Cease Trade Order

January 22, 2009

Cease Trade Order

January 20, 2009

← Newer news releases

Decks